NCT04451005

Brief Summary

Sarcopenia is a generalized progressive skeletal muscle disorder that represents a related physiological vulnerability that is associated with or increases the likelihood of adverse outcomes, including falls, fractures, physical disability and death. The parameters used to assess sarcopenia in clinical practice have limited use due to their custody. In this perspective, this study proposes or develops a tool for the diagnosis of having sarcopenia with a specific boa and a sensitive boa. low cost and useful. Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected This study was of clinical importance, due to sarcopenia and a relevant factor, and could lead to consequences and poor prognosis in patients with gold, and it was not a method of clinical practice to properly endorse body composition in this population.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
403

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2018

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
Last Updated

June 30, 2020

Status Verified

June 1, 2020

Enrollment Period

2 years

First QC Date

June 2, 2020

Last Update Submit

June 25, 2020

Conditions

Sarcopenia

Keywords

Body compositionSarcopeniaElderly

Outcome Measures

Primary Outcomes (1)

  • Sarcopenia in the elderly

    Evaluation of sarcopenia in the elderly

    12 months

Secondary Outcomes (1)

  • Development of a new tool for sarcopenia screening

    12 months

Study Arms (1)

Elderly patients with sarcopenia

Elderly patients with sarcopenia

Other: 0

Interventions

0OTHER

Elderly patients with sarcopenia

Elderly patients with sarcopenia

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly patients over 60 years old, with cognitive ability and interested in participating in the study

You may qualify if:

  • Age ≥ 60 years
  • Sign free and informed consent;
  • Demonstrate interest, conditions and availability to participate in all procedures included in the study protocol;

You may not qualify if:

  • Refusal to participate;
  • Patients who have not undergone cognitive testing;
  • Physical amputation;
  • Patients undergoing interventional treatment for sarcopenia;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal researcher

Study Record Dates

First Submitted

June 2, 2020

First Posted

June 30, 2020

Study Start

May 6, 2016

Primary Completion

May 6, 2018

Study Completion

December 10, 2019

Last Updated

June 30, 2020

Record last verified: 2020-06